Clinical trial
The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting
NCT03057340 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- June 1, 2017
- Completion date
- December 1, 2020
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.